Skip to main content
. 2020 Jul 27;13:469–477. doi: 10.2147/CCID.S262691

Table 2.

Descriptive Statistics (Mean [M], Standard Deviation [SD], Lower Limit [LL], Upper Limit [UL] and Confidence Interval [CI]) in DLQI and Skindex-29 Scales (Total, Physical Symptoms, Psychosocial Functioning, and Emotional Experiences) for the AA and PA Groups, at Baseline and 12 Weeks After Treatment

Variables AA Group (n = 60)
Before Treatment After Treatment
M SD 95% CI M SD 95% CI
LL UL LL UL
Skindex-29 Total 3.64 0.05 3.54 3.74 2.16 0.05 2.06 2.26
 Physical symptoms 3.70 0.05 3.59 3.80 2.20 0.05 2.09 2.30
 Psychosocial functioning 3.62 0.05 3.52 3.73 2.13 0.05 2.02 2.24
 Emotional experiences 3.63 0.05 3.52 3.74 2.17 0.05 2.07 2.28
DLQI 22.33 0.38 21.58 23.09 8.33 0.44 7.45 9.21
Variables PA Group (n = 60)
Before Treatment After Treatment
M SD 95% CI M SD 95% CI
LL UL LL UL
Skindex-29 Total 3.87 0.05 3.77 3.97 2.00 0.05 1.90 2.10
 Physical symptoms 3.88 0.05 3.77 3.98 1.99 0.05 1.88 2.09
 Psychosocial functioning 3.85 0.05 3.75 3.95 2.02 0.05 1.91 2.12
 Emotional experiences 3.90 0.05 3.79 4.00 1.99 0.05 1.89 2.10
DLQI 23.30 0.38 22.55 24.05 7.58 0.44 6.70 8.46

Abbreviations: AA, azelaic acid; PA, pyruvic acid; DLQI, Dermatology Life Quality Index.